Gabet, Stephan
Thierry, Benoit
Wasfi, Rania
Simonelli, Guido
Hudon, Catherine
Lessard, Lily
Dubé, Ève
Nasri, Bouchra
Kestens, Yan
Moullec, Grégory
Funding for this research was provided by:
Ministère de l'Économie, de la Science et de l'Innovation - Québec (52266, 52266)
Public Health Agency of Canada (4500416825 – 450041483, 4500416825 – 450041483)
Article History
Received: 22 September 2022
Accepted: 22 November 2023
First Online: 2 December 2023
Declarations
:
: Before completing the eligibility questionnaire, potential participants are first invited to read the consent form and provide an electronic written consent to participate in the study. Informed consent was obtained from all the participants and/or their legal guardians. In Phase 2, a second consent will be required from participant wishing to register for the prospective follow-ups after having completed baseline questionnaire. Phase 1 COHESION was approved by the ethics board of the <i>Centre de Recherche du Centre Hospitalier de l’Université de Montréal</i> (CRCHUM; MP-02-2021-8924) and by the <i>Public Health Agency of Canada</i> (PHAC) ethical review board (REB 2020-016P). Phase 2 COHESION was approved by both the ethics board of the <i>Centre Intégré Universitaire de Santé et de Services Sociaux du Nord-de-l’Île-de-Montréal</i> (CIUSSS-NIM ; 2022–2327) and PHAC (REB 2020-016P).
: Not applicable.
: YK holds shares in Polygon Research Inc., the data collection platform that is used for the COHESION study. Other authors have no competing interests to declare.